Acyclovir NDC 71205-472

Product information

Brand name (proprietary)

Acyclovir

Generic name (nonproprietary)

acyclovir

Active ingredients

Acyclovir — 400 mg/1

Dosage form

Tablet

Route

Oral

Labeler

Proficient Rx LP

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 210401

Marketing start

May 4, 2018

Listing expires

Dec 31, 2026

Other FDA classes

DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)

Identifiers

Product ID 71205-472_17c98e9b-bcc4-4909-b6ce-0e11d786081aSPL ID 17c98e9b-bcc4-4909-b6ce-0e11d786081aSPL set ID 290af212-7332-4914-9ef0-65760478fb32RxCUI 197311UNII X4HES1O11FUPC 0371205472306

Pharmacologic class

Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205047215 followed by a unit qualifier and the quantity Copy

Package 71205-0472-15. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 210401

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.